1. Home
  2. WCCB vs PHAT Comparison

WCCB vs PHAT Comparison

Compare WCCB & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WCCB

West Coast Community Bancorp Common Stock

N/A

Current Price

$61.16

Market Cap

632.6M

Sector

Finance

ML Signal

N/A

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

N/A

Current Price

$7.29

Market Cap

590.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WCCB
PHAT
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
632.6M
590.6M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
WCCB
PHAT
Price
$61.16
$7.29
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
★ $67.00
$20.45
AVG Volume (30 Days)
34.9K
★ 1.2M
Earning Date
09-23-2026
10-29-2026
Dividend Yield
★ 1.64%
N/A
EPS Growth
N/A
★ 42.72
EPS
★ N/A
N/A
Revenue
N/A
★ $175,110,000.00
Revenue This Year
$6.43
$80.58
Revenue Next Year
$6.14
$56.62
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 216.93
52 Week Low
$58.91
$6.52
52 Week High
$61.95
$18.31

Technical Indicators

Market Signals
Indicator
WCCB
PHAT
Relative Strength Index (RSI) 78.85 42.53
Support Level $59.77 $6.91
Resistance Level $61.95 $9.74
Average True Range (ATR) 0.88 0.36
MACD 0.09 0.05
Stochastic Oscillator 55.39 56.06

Price Performance

Historical Comparison
WCCB
PHAT

About WCCB West Coast Community Bancorp Common Stock

West Coast Community Bancorp is a bank holding company. Through its banking subsidiary, it offers a full range of commercial and personal banking services to residents and businesses in Santa Cruz County and adjacent Monterey, San Luis Obispo, and Santa Clara counties. Its products and service offerings include mobile banking, credit and debit cards, treasury management, deposit products, such as checking, savings, and term certificate accounts, and lending products such as commercial, commercial real estate, construction, multifamily, municipal, asset-backed loans, etc. Its lending products also include various government guarantee programs such as Small Business Administration (SBA) and 504 programs, as well as U.S. Department of Agriculture (USDA) programs.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: